Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.verified

ATXI

Price:

$1.73

Market Cap:

$3.55M

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.[Read more]

Industry

Biotechnology

IPO Date

2017-06-27

Stock Exchange

NASDAQ

Ticker

ATXI

The PE Ratio as of December 2024 (TTM) for Avenue Therapeutics, Inc. (ATXI) is 0.07

According to Avenue Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.07. This represents a change of -99.77% compared to the average of 29.99 of the last 4 quarters.

Avenue Therapeutics, Inc. (ATXI) Historical PE Ratio (quarterly & annually)

How has ATXI PE Ratio performed in the past?

The mean historical PE Ratio of Avenue Therapeutics, Inc. over the last ten years is -573.34. The current 0.07 PE Ratio has changed -101.22% with respect to the historical average. Over the past ten years (40 quarters), ATXI's PE Ratio was at its highest in in the September 2023 quarter at 204.51. The PE Ratio was at its lowest in in the September 2020 quarter at -3263.12.

Quarterly (TTM)
Annual

Average

-573.34

Median

-310.83

Minimum

-1721.96

Maximum

92.83

Avenue Therapeutics, Inc. (ATXI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Avenue Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 226.72%

Maximum Annual PE Ratio = 92.83

Minimum Annual Increase = -129.86%

Minimum Annual PE Ratio = -1721.96

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.16-100.18%
202292.83-129.86%
2021-310.83-78.53%
2020-1447.44226.72%
2019-443.02127.34%
2018-194.8732.61%
2017-146.96-91.47%
2016-1721.9674.35%

Avenue Therapeutics, Inc. (ATXI) Average PE Ratio

How has ATXI PE Ratio performed in the past?

The current PE Ratio of Avenue Therapeutics, Inc. (ATXI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-72.72

5-year avg

-421.73

10-year avg

-573.34

Avenue Therapeutics, Inc. (ATXI) PE Ratio vs. Peers

How is ATXI’s PE Ratio compared to its peers?

Avenue Therapeutics, Inc.’s PE Ratio is greater than Hoth Therapeutics, Inc. (-0.71), greater than Revelation Biosciences, Inc. (-0.05), greater than NeuroBo Pharmaceuticals, Inc. (-0.87), greater than Virax Biolabs Group Limited (-0.58), greater than Panbela Therapeutics, Inc. (-0.06), greater than Palisade Bio, Inc. (-0.18), greater than Quoin Pharmaceuticals, Ltd. (-0.28), greater than ContraFect Corporation (-0.00), greater than Allarity Therapeutics, Inc. (-0.08), greater than CNS Pharmaceuticals, Inc. (-0.14), greater than Windtree Therapeutics, Inc. (-0.03), less than Kiromic BioPharma, Inc. (0), greater than Biodexa Pharmaceuticals Plc (-1.13), greater than null (-0.16),

Build a custom stock screener for Avenue Therapeutics, Inc. (ATXI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avenue Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avenue Therapeutics, Inc. (ATXI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avenue Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Avenue Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Avenue Therapeutics, Inc. (ATXI)?

What is the highest PE Ratio for Avenue Therapeutics, Inc. (ATXI)?

What is the 3-year average PE Ratio for Avenue Therapeutics, Inc. (ATXI)?

What is the 5-year average PE Ratio for Avenue Therapeutics, Inc. (ATXI)?

How does the current PE Ratio for Avenue Therapeutics, Inc. (ATXI) compare to its historical average?